The global Immunohistochemistry Market size is expected to
reach USD 3.92 billion by 2030, according to a new report by Grand View
Research, Inc. The market is expected to register a CAGR of 8.4% during the
forecast period. The high demand for accurate data has driven several technological
advancements in IHC techniques, resulting in the delivery of precise and
contextual data analyses. The emergence of advanced techniques, such as
multiplex IHC, computational pathology, and next-generation IHC, is driving the
global market. Immunohistochemistry protocols have gained popularity in
clinical pathology, especially in the subspecialties of oncologic pathology,
hematopathology, and neuropathology.
The technique has played a vital role in shaping cancer
diagnostics. Thus, the growing prevalence of cancer is expected to increase the
demand for IHC, thus contributing to market growth. Furthermore, the wide
application scope of IHC in drug discovery and development activities is
expected to boost revenue growth over the forecast period. Whole slide imaging
and digital image analysis offer highly accurate and objective evaluations.
Thus, image analysis can be used across different aspects of drug discovery
including drug repositioning, target validation, patient stratification,
biomarker expression studies, and drug efficacy & safety studies.
Acknowledging the profitable opportunities posed by
the space, operating players in the industry continue to undertake strategic
initiatives to strengthen their market presence. For instance, in June 2021,
PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd.,
created machine learning-based models to enable automated quantification of HER2
IHC images in breast cancer samples. The global market will benefit from the
growing geriatric population in developed and developing nations. As the global
geriatric population increases, the prevalence of age-related illnesses is
predicted to rise drastically.
Related Press Release@ Immunohistochemistry Market Report
Immunohistochemistry Market
Report Highlights
- The antibodies product segment led the market in 2021 owing to the
high use of antibodies for immunohistochemistry assays carried out for
disease diagnosis and drug testing workflows
- The diagnostics application segment led the market in 2021 owing to
the widespread application of IHC tests in diagnostic settings
- The drug testing segment is expected to witness significant growth
during the forecast period. This is due to increasing investment flow by
pharmaceutical companies in R&D activities of novel drug discovery and
development
- The hospitals and diagnostic laboratories end-use segment accounted
for the largest revenue share in 2021. Research institutes are expected to
register the fastest CAGR over the forecast period owing to the increasing
adoption of IHC in research institutes for drug discovery activities
- North America emerged as the largest regional market in 2021 owing
to the confluence of multiple factors, such as high cancer prevalence,
presence of key players, and developed healthcare & biotechnological
sectors
- The Asia Pacific is projected to grow at the fastest CAGRover the
forecast period with China being the fastest-growing market. Increasing
regulatory approvals and the launch of novel IHC solutions in China are
accelerating the country’s market growth
- Key players are engaged in making focused attempts to reinforce
their market position and gain a competitive advantage
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment